| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-09 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |